Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord InjuryNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, palsy, quadriplegiaRecruitingPhase 32026-10-05NCT07799532

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
NervGen Pharma1

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
International Neurorehabilitation InstituteLuthervilleUnited States2
NervGen NVG-291-301 Site#101AtlantaUnited States1
NervGen NVG-291-301 Site#102MilwaukeeUnited States1
NervGen NVG-291-301 Site#104BirminghamUnited States1
NervGen NVG-291-301 Site#106EnglewoodUnited States1
NervGen NVG-291-301 Site#107MiamiUnited States1
NervGen NVG-291-301 Site#108CharlotteUnited States1
NervGen NVG-291-301 Site#109DowneyUnited States1
NervGen NVG-291-301 Site#110HoustonUnited States1
NervGen NVG-291-301 Site#111RochesterUnited States1
NervGen NVG-291-301 Site#112Washington D.C.United States1
NervGen NVG-291-301 Site#113CharlestonUnited States1
NervGen NVG-291-301 Site#114West OrangeUnited States1
NervGen NVG-291-301 Site#115CamdenUnited States1
NervGen NVG-291-301 Site#116PhiladelphiaUnited States1
NervGen NVG-291-301 Site#117ParamusUnited States1
NervGen NVG-291-301 Site#201VancouverCanada1
New England Institue for Clinical ResearchStamfordUnited States1